Fiserv Inc (BSP:F1IS34)
R$ 125.77 +0.72 (+0.58%) Market Cap: 133.76 Bil Enterprise Value: 275.68 Bil PE Ratio: 9.39 PB Ratio: 0.97 GF Score: 74/100

Fiserv Inc at Goldman Sachs Communacopia + Technology Conference Transcript

Sep 10, 2026 / 09:25PM GMT
Release Date Price: R$125.77 (+0.58%)
William Nance Goldman Sachs;Analyst

All right. We're going to get started on the next session. I am pleased to have a twofer here. We have Takis Giorgiakopoulos, Pfizer's CEO, and Paul Todd, Pfizer's CFO.

Thank you both for joining us.

Thank you.

Questions & Answers

William Nance Goldman Sachs;Analyst

All right, Takis, to open this up, you've been in the CEO seat for almost three months now. We've heard a lot from the team at Investor Day in May about the company's strategy. You've since talked about bringing more urgency and focus to the execution. So could you talk about your top priorities and are there any areas where you've made tweaks to what was previously communicated at that Investor Day?

Takis Georgakopoulos Fiserv Inc;Chief Executive Officer

Yeah. So first of all, thank you for having us. I would say overall, in terms of the priorities of the company, as we communicated with the one Pfizer priority, these are pretty self-explanatory things. They're about

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
7-Day Free Trial · Cancel Anytime
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot